GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (XMAD:ALM) » Definitions » Common Stock

Almirall (XMAD:ALM) Common Stock : €0.0 Mil (As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Almirall Common Stock?

Almirall's quarterly common stock increased from Mar. 2024 (€0.0 Mil) to Jun. 2024 (€25.6 Mil) but then declined from Jun. 2024 (€25.6 Mil) to Sep. 2024 (€0.0 Mil).

Almirall's annual common stock increased from Dec. 2021 (€21.6 Mil) to Dec. 2022 (€21.8 Mil) and increased from Dec. 2022 (€21.8 Mil) to Dec. 2023 (€25.1 Mil).


Almirall Common Stock Historical Data

The historical data trend for Almirall's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Almirall Common Stock Chart

Almirall Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.95 21.37 21.57 21.78 25.13

Almirall Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 25.13 - 25.62 -

Almirall Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Almirall Business Description

Traded in Other Exchanges
Address
Ronda General Mitre 151, Barcelona, ESP, 08022
Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.

Almirall Headlines

From GuruFocus

Alfi: Solid Growth Potential Lies Ahead

By Ishan Majumdar Ishan Majumdar 06-02-2021

ALFI Inc: A Little Known Yet Compelling Ad-Tech Play

By Ishan Majumdar Ishan Majumdar 05-07-2021